Finepoint Capital LP
An institutional investment manager in BOSTON, MA. Its Form 13F for the quarter ended Jun 30, 2026, filed Aug 13, 2026. SEC CIK 1608126.
- Reported value$2.80bn
- Positions9
Holdings: 9 positions
The filing on sec.govAs filed, largest first. Reported value is what the manager stated for each position at the quarter end, in US dollars; it is filing data, not a price. Weight is the position's share of the total reported value. Changes compare with the 13F for the quarter ended 2026-03-31.
| Issuer | Class | CUSIP | Reported value$m | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| SPDR S&P 500 ETF TRSPY | TR UNIT | 78462F103 | 1,278 | 45.7% | 1,711,800 | Put | Added+657,100 |
| Microsoft CorpMSFT | COM | 594918104 | 592 | 21.2% | 1,587,400 | Call | New+1,587,400 |
| Invesco QQQ TR | UNIT SER 1 | 46090E103 | 467 | 16.7% | 634,755 | Put | Unchanged |
| QXO IncQXO | COM NEW | 82846H405 | 313 | 11.2% | 18,113,850 | Added+4,255,435 | |
| RXO IncRXO | COMMON STOCK | 74982T103 | 148 | 5.3% | 5,355,445 | Reduced−4,718,173 | |
| Aleanna IncANNA | *W EXP 12/13/202 | 01444V111 | 0.1 | <0.1% | 490,000 | Unchanged | |
| Aleanna IncANNA | COM CL A | 01444V103 | 0.1 | <0.1% | 27,717 | Unchanged | |
| Moneyhero Limited | *W EXP 09/13/202 | G6202B119 | 0.0 | <0.1% | 895,000 | Unchanged | |
| Calidi Biotherapeutics Inc | COM | 320703408 | 0.0 | <0.1% | 1,042 | Unchanged |
Sold out: 1 position
Held at the end of the quarter before and not reported this quarter.
| Issuer | Class | CUSIP | Reported value$ | Weight | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|---|---|
| Ishares TR | ISHARES SEMICDTR | 464287523 | 0.0 | 0.0% | 0 | Put | Sold out−1,469,968 |
Source: SEC EDGAR, Form 13F-HR, accession 0000904454-26-000450 (on sec.gov). Last ingested by Listed: Oct 22, 2026, 05:26 ET. Listed shows no prices and gives no investment advice.